ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,092.45
      -0.84%
      US Tech 100
      21,397.20
      -0.85%
      Dow Jones
      44,185.25
      -0.99%
      Brent Oil
      76.275
      0.60%
      Bitcoin
      97,035.74
      0.42%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Compass Therapeutics Inc (CMPX) Quote

      Compass Therapeutics Inc

      Compass Therapeutics Inc (CMPX)

      NASDAQ
      3.23
      -0.15
      ( -4.44% )
      Updated: 09:54:54
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      3.23
      Bid
      3.22
      Ask
      3.24
      Volume
      167,399
      3.172 Day's Range 3.28
      0.765 52 Week Range 4.08
      Market Cap
      444.413M
      Previous Close
      3.38
      Open
      3.26
      Last Trade
      1
      @
      3.23
      Last Trade Time
      09:55:22
      Financial Volume
      $ 538,611
      VWAP
      3.2175
      Average Volume (3m)
      1,422,010
      Shares Outstanding
      137,589,171
      Dividend Yield
      -
      PE Ratio
      -10.95
      Earnings Per Share (EPS)
      -0.31
      Revenue
      -
      Net Profit
      -42.49M

      About Compass Therapeutics Inc

      Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engi... Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.compasstherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Compass Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CMPX. The last closing price for Compass Therapeutics was $3.38. Over the last year, Compass Therapeutics shares have traded in a share price range of $ 0.765 to $ 4.08.

      Compass Therapeutics currently has 137,589,171 shares outstanding. The market capitalization of Compass Therapeutics is $465.05 million. Compass Therapeutics has a price to earnings ratio (PE ratio) of -10.95.

      Ask ADVFN Intelligence (AI)

      CMPX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 13 2025
      CMPX (-4.44%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 13 2025
      CMPX (-4.44%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 13 2025
      CMPX (-4.44%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 13 2025
      CMPX (-4.44%)

      Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
      Edgar (US Regulatory)
      February 04 2025
      CMPX (-4.44%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 08 2025
      CMPX (-4.44%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.49-13.17204301083.723.853.13510354323.34084275CS
      40.154.870129870133.084.082.52513920153.28060991CS
      121.63101.8751.64.081.3314220102.36175598CS
      262.04171.4285714291.194.081.158816872.14134273CS
      521.3470.89947089951.894.080.7656189581.94082013CS
      1560.9239.82683982682.315.650.7654211952.33782286CS
      260-0.87-21.21951219514.15.650.7653771142.37262006CS

      CMPX - Frequently Asked Questions (FAQ)

      What is the current Compass Therapeutics share price?
      The current share price of Compass Therapeutics is $ 3.23
      How many Compass Therapeutics shares are in issue?
      Compass Therapeutics has 137,589,171 shares in issue
      What is the market cap of Compass Therapeutics?
      The market capitalisation of Compass Therapeutics is USD 465.05M
      What is the 1 year trading range for Compass Therapeutics share price?
      Compass Therapeutics has traded in the range of $ 0.765 to $ 4.08 during the past year
      What is the PE ratio of Compass Therapeutics?
      The price to earnings ratio of Compass Therapeutics is -10.95
      What is the reporting currency for Compass Therapeutics?
      Compass Therapeutics reports financial results in USD
      What is the latest annual profit for Compass Therapeutics?
      The latest annual profit of Compass Therapeutics is USD -42.49M
      What is the registered address of Compass Therapeutics?
      The registered address for Compass Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Compass Therapeutics website address?
      The website address for Compass Therapeutics is www.compasstherapeutics.com
      Which industry sector does Compass Therapeutics operate in?
      Compass Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WOKWORK Medical Technology Group Ltd
      $ 4.9697
      (99.59%)
      		61.37M
      XOSXos Inc
      $ 6.20
      (98.08%)
      		19.07M
      SHOTWSafety Shot Inc
      $ 0.37
      (73.55%)
      		10.27k
      RETOReTo Eco Solutions Inc
      $ 0.5855
      (48.23%)
      		5.55M
      MNDRMobile health Network Solutions
      $ 0.4469
      (35.71%)
      		45.43M
      MTLSMaterialise NV
      $ 6.4753
      (-29.77%)
      		267.11k
      PTIRGraniteShares 2X Long PLTR Daily ETF
      $ 201.6231
      (-22.07%)
      		437.77k
      PLTUDirexion DAily PLTR Bull 2X Shares
      $ 42.9319
      (-21.64%)
      		1.29M
      TALKTalkspace Inc
      $ 3.0789
      (-20.24%)
      		2.2M
      PTPIPetros Pharmaceuticals Inc
      $ 0.1258
      (-20.23%)
      		4.62M
      APTOAptose Biosciences Inc
      $ 0.1986
      (32.49%)
      		129.58M
      ADTXAditxt Inc
      $ 0.1112
      (-13.53%)
      		71.8M
      FGENFibroGen Inc
      $ 0.6999
      (24.54%)
      		67.98M
      PLTRPalantir Technologies Inc
      $ 100.09
      (-10.68%)
      		62.12M
      WOKWORK Medical Technology Group Ltd
      $ 4.931
      (98.03%)
      		61.4M

      CMPX Discussion

      View Posts
      Monksdream Monksdream 1 week ago
      CMPX, new 52=week high
      👍️0
      Tiger Money Tiger Money 1 week ago
      Man!  It has been some time!  You are one of the few money makers that I have met on ihub.  I always appreciate and laugh at your lack of tolerance for stupidity.  

      Need your thoughts as I know u r more technical, but the fundamentals behind this name are scary good.  This low float could run massively (sound like 47) as they have cash until 2027 and about to potentially get some solid results from their phase 2/3 study. I have simply tripled my money waiting....
      👍️0
      TrendTrade2016 TrendTrade2016 1 week ago
      CMPX bio beast breakout
      👍️0
      Tiger Money Tiger Money 3 weeks ago
      Yep, seems like it makes a new 52 week high 3-4 times a week.  Someone must know something 
      👍️0
      Monksdream Monksdream 3 weeks ago
      CMPX, new 52/high
      👍️0
      Tiger Money Tiger Money 3 weeks ago
      What does this tell us?  Thanks 
      👍️0
      glenn1919 glenn1919 3 weeks ago
      CMPX............................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Tiger Money Tiger Money 4 weeks ago
      What does this tell you?  Thanks!
      👍️0
      glenn1919 glenn1919 4 weeks ago
      CMPX...........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Tiger Money Tiger Money 4 weeks ago
      the upcoming trials....apparently someone(s) may know the results?  The initial indication is that they were very good 
      👍️0
      Bucks79 Bucks79 4 weeks ago
      broke out after consolidation.. don't see any news released?
      👍️0
      glenn1919 glenn1919 4 weeks ago
      CMPX..............https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      PonkenPlonken PonkenPlonken 1 month ago
      listen to the webcasts and you will find mindblowing things every now and then. Like 6 out of 22 patients with 40% tumor decline in vegf dll4 monotherapy data.
      And some people say theres a way to make the machine listen.
      👍️0
      Tiger Money Tiger Money 1 month ago
      Someone must know something.... 
      👍️0
      Bucks79 Bucks79 1 month ago
      a lot of action on this one in the last few days.
      👍️0
      glenn1919 glenn1919 1 month ago
      CMPX........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Tiger Money Tiger Money 1 month ago
      Gap filled 
      👍️0
      PonkenPlonken PonkenPlonken 1 month ago
      and they didnt even speak about it today!
      👍️0
      Tiger Money Tiger Money 1 month ago
      Some very good news out this morning!
      👍️0
      glenn1919 glenn1919 1 month ago
      CMPX..................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Tiger Money Tiger Money 2 months ago
      Thanks!
      👍️0
      glenn1919 glenn1919 2 months ago
      sideways................higher lows.....possible breakout
      👍️0
      Tiger Money Tiger Money 2 months ago
      What does your work tell you on this?  Thanks 
      👍️0
      glenn1919 glenn1919 2 months ago
      cmpx.........................https://stockcharts.com/h-sc/ui?s=cmpxp=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 2 months ago
      CMPX, under $2
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      Sorry for the late reply, your question got lost in the mailbox.
      I believe 3-6$ isnt unreasonable if they publish a nice readout.

      i believe a handful of patients showed more than 30% tumor shrinkage in vegf monotherapy data... I havent seen similar to date...... Nobody listens to webcasts anymore - they probably need an anaylst note to alert them LOL
      VEGf space is full of scammers to... everyone jumped the train
      👍 1
      Tiger Money Tiger Money 3 months ago
      If so, where do you think that puts the stock?  Thanks 
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      Wouldnt be surprised to see a partner announced in the 10q
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      boom coming never before monotherapy data in VEGF space.... a place flooded by bio grifters
      👍️0
      Monksdream Monksdream 4 months ago
      CMPX under $2
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      high volume yesterday
      👍️0
      PonkenPlonken PonkenPlonken 5 months ago
      EXCELLENT monotherapy data
      VEGF targeted agents usually need the chemo combination to even get a signifcant response. They get it in monotherapy.
      I think its going to run into the H1 2025 data.
      👍️0
      Monksdream Monksdream 6 months ago
      CMPX under $2
      👍️0
      glenn1919 glenn1919 6 months ago
      CMPX........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 7 months ago
      CMPX....................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 7 months ago
      CMPX under $2
      👍️0
      Monksdream Monksdream 11 months ago
      CMPX 10Q due 3/25
      👍️0
      Monksdream Monksdream 11 months ago
      CMPX 10Q due 3/18
      👍️0
      glenn1919 glenn1919 11 months ago
      CMPX....................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 11 months ago
      Cant say offhand
      Read the latest 10Q
      👍️0
      stockweiser stockweiser 11 months ago
      Do you know there current cash on hand?
      👍️0
      Monksdream Monksdream 11 months ago
      CMPX 10Q due March 11
      👍️0
      Monksdream Monksdream 1 year ago
      CMPX new 52=week low
      👍️0
      Monksdream Monksdream 1 year ago
      CMPX new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CMPX under $2
      👍️0
      Copilotdog Copilotdog 1 year ago
      Solid company
      👍️0
      Mktman2024 Mktman2024 2 years ago
      Compass to review latest phase 2 progress with CTX 009 and other items at ASCO Jan 19-21.
      Company moving slowly into the spotlight.
      👍️0
      Mktman2024 Mktman2024 2 years ago
      Reminder CMPX is Compass Therapeutics ,,,EF Hutton new target 10
      targets range from 8-15
      👍️0
      Mktman2024 Mktman2024 2 years ago
      https://www.streetinsider.com/Corporate+News/Compass+Therapeutics%2C+Inc+%28CMPX%29+doses+first+patient+in+Phase+1b+CTX-471+combo+with+KEYTRUDA/20920046.html

      now were talking!!
      👍️0
      Mktman2024 Mktman2024 2 years ago
      amazing no one posts on any CMPX boards except twitter ...and even then crickets
      👍️0

      Your Recent History

      NASDAQ
      CMPX
      Compass Therapeutics
      USOTC
      CHIT
      Cherubim Interests (CE)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads